BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MedTest DX, Inc., Purchases Chemistry Product Line from Polymedco


5/16/2011 8:46:49 AM

CORTLANDT MANOR, N.Y., May 16, 2011 /PRNewswire/ -- Polymedco, Inc. ("Polymedco") is pleased to announce the acquisition by MedTest DX, Inc. of Polymedco's complete line of chemistry products which was effective April 20th, 2011. The transaction includes the Poly-Chem® benchtop chemistry analyzer, and all related reagents; the SPOTCHEM EZ® small dry benchtop chemistry analyzer and all related reagents, and all bulk chemistry reagents.

MedTest, DX, Inc. ("MedTest") was incorporated in 2011 as part of the purchase of chemistry assets from Polymedco. The investment in MedTest was made by Enhanced Equity Fund, a healthcare focus private equity firm. MedTest, based in Cortlandt Manor, NY, will sell a range of chemistry instruments, reagents, and instrument services to physician offices, hospitals, reference laboratories, and research facilities, through distribution channels in the U.S.

Commenting on the transaction, James White CEO of MedTest said, "I am excited to be working with Drew Cervasio and his team at Polymedco as we grow our chemistry business under the MedTest DX name and look to build on the excellent reputation Polymedco and their suppliers have in the marketplace."

"We are very pleased with this recent transaction of selling our chemistry business to EEF," said Drew Cervasio, President of Polymedco, "they will be a thoroughly focused chemistry and point of care company and will be extremely successful. We look forward to working with them to support customers in a seamless transition."

Polymedco Inc. is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and devices that are specialized in hematology and cancer. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC FIT-CHEK® product line.

Since 1980, Polymedco has evolved into a highly skilled and successful marketing, sale, and manufacturing organization. With an experienced team of field representatives combined with strong technical service personnel, Polymedco provides a high level of customer, technical and reimbursement support.

SOURCE Polymedco, Inc.



Read at BioSpace.com

Polymedco
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES